About this trial
This is a two-arm, prospective, controlled observational pilot clinical study aimed at characterizing the lipidomic profile and extracellular vesicles (EVs) of patients with autoimmune hepatitis (AIH) compared to patients with non-alcoholic fatty liver disease (NAFLD). A total of 24 adult outpatients will be enrolled at the Hepatology Outpatient Unit of IRCCS "S. de Bellis". Blood samples will be collected by venipuncture to perform lipidomic analyses on red blood cell membranes and serum, and to isolate and characterize EVs. No intervention beyond standard clinical practice will be applied
Eligibility criteria
Qualifiers
Confirmed diagnosis of autoimmune hepatitis (AIH);
Adult age (≥18 years);
Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis"
Disqualifiers
Confirmed diagnosis of non-alcoholic fatty liver disease (NAFLD);
Adult age (≥18 years);
Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis"
Liver cirrhosis;
Trial design
Treatments tested in this trial
- Not listed